PMID- 36848775 OWN - NLM STAT- MEDLINE DCOM- 20230316 LR - 20230401 IS - 1879-1379 (Electronic) IS - 0022-3956 (Linking) VI - 160 DP - 2023 Apr TI - GRIN2B gene expression is increased in the anterior cingulate cortex in major depression. PG - 204-209 LID - S0022-3956(23)00076-6 [pii] LID - 10.1016/j.jpsychires.2023.02.017 [doi] AB - The glutamatergic system may be central to the neurobiology and treatment of major depressive disorder (MDD) and psychosis. Despite the success of N-methyl-D-aspartate receptor (NMDAR) antagonists for the treatment of MDD, little is known regarding the expression of these glutamate receptors in MDD. In this study we measured gene expression, via qRT-PCR, of the major NMDAR subunits, in the anterior cingulate cortex (ACC) in MDD subjects with and without psychosis, and non-psychiatric controls. Overall, GRIN2B mRNA was increased in both MDD with (+32%) and without psychosis (+40%) compared to controls along with a trend increase in GRIN1 mRNA in MDD overall (+24%). Furthermore, in MDD with psychosis there was a significant decrease in the GRIN2A:GRIN2B mRNA ratio (-19%). Collectively these results suggest dysfunction of the glutamatergic system at the gene expression level in the ACC in MDD. Increased GRIN2B mRNA in MDD, along with an altered GRIN2A:GRIN2B ratio in psychotic depression, suggests a disruption to NMDAR composition could be present in the ACC in MDD; this could lead to enhanced signalling via GluN2B-containing NMDARs and greater potential for glutamate excitotoxicity in the ACC in MDD. These results support future research into GluN2B antagonist-based treatments for MDD. CI - Copyright (c) 2023 Elsevier Ltd. All rights reserved. FAU - Brown, Samara J AU - Brown SJ AD - School of Medical, Indigenous and Health Sciences and Molecular Horizons, University of Wollongong, Wollongong, New South Wales, 2522, Australia; Illawarra Health and Medical Research Institute, Wollongong, New South Wales, 2522, Australia. FAU - Brown, Amelia M AU - Brown AM AD - Schizophrenia Research Laboratory, Neuroscience Research Australia, Randwick, New South Wales, 2031, Australia. FAU - Purves-Tyson, Tertia D AU - Purves-Tyson TD AD - Schizophrenia Research Laboratory, Neuroscience Research Australia, Randwick, New South Wales, 2031, Australia; Discipline of Psychiatry and Mental Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, 2031, Australia. FAU - Huang, Xu-Feng AU - Huang XF AD - School of Medical, Indigenous and Health Sciences and Molecular Horizons, University of Wollongong, Wollongong, New South Wales, 2522, Australia; Illawarra Health and Medical Research Institute, Wollongong, New South Wales, 2522, Australia. FAU - Shannon Weickert, Cynthia AU - Shannon Weickert C AD - Schizophrenia Research Laboratory, Neuroscience Research Australia, Randwick, New South Wales, 2031, Australia; Discipline of Psychiatry and Mental Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, 2031, Australia; Department of Neuroscience & Physiology, Upstate Medical University, Syracuse, NY, 13210, USA. FAU - Newell, Kelly A AU - Newell KA AD - School of Medical, Indigenous and Health Sciences and Molecular Horizons, University of Wollongong, Wollongong, New South Wales, 2522, Australia; Illawarra Health and Medical Research Institute, Wollongong, New South Wales, 2522, Australia. Electronic address: knewell@uow.edu.au. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230216 PL - England TA - J Psychiatr Res JT - Journal of psychiatric research JID - 0376331 RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 0 (RNA, Messenger) RN - 0 (NR2B NMDA receptor) SB - IM MH - Humans MH - Depression/psychology MH - *Depressive Disorder, Major/genetics MH - Gene Expression MH - Gyrus Cinguli/metabolism MH - *Receptors, N-Methyl-D-Aspartate/metabolism MH - RNA, Messenger/metabolism OTO - NOTNLM OT - Anterior cingulate cortex OT - Depression OT - GRIN2B OT - Glutamate OT - NMDA EDAT- 2023/02/28 06:00 MHDA- 2023/03/15 06:00 CRDT- 2023/02/27 18:28 PHST- 2022/07/07 00:00 [received] PHST- 2023/01/16 00:00 [revised] PHST- 2023/02/14 00:00 [accepted] PHST- 2023/02/28 06:00 [pubmed] PHST- 2023/03/15 06:00 [medline] PHST- 2023/02/27 18:28 [entrez] AID - S0022-3956(23)00076-6 [pii] AID - 10.1016/j.jpsychires.2023.02.017 [doi] PST - ppublish SO - J Psychiatr Res. 2023 Apr;160:204-209. doi: 10.1016/j.jpsychires.2023.02.017. Epub 2023 Feb 16.